MNAT News Alert Marquette Natl Cp (MNAT) 96.0000 02/15/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Marquette Natl Cp (MNAT) 96.0000 $MNAT

Marquette National Corporation Announces Common Stock Repurchase Program
PR Newswire - Fri Feb 13, 9:05AM CST
Marquette National Corporation (OTCQX: MNAT) today announced that its Board of Directors has authorized the repurchase of up to $500,000 of its outstanding common stock at prevailing market prices through open market or negotiated transactions. The repurchase program is authorized to last through December 31, 2015. As of January 31, 2015, Marquette had 1,025,109 shares issued and outstanding.

Marquette National announces 50% higher dividend of USD0.375 per share over prior quarter
M2 - Thu Jan 22, 4:28AM CST
Marquette National Corporations (OTCQX:MNAT), a diversified bank holding company, reported on Wednesday that its board of directors authorised a cash dividend of USD0.375 per share, up 50% from the previous quarter's dividend rate, on the company's 1,025,109 shares issued and outstanding as of 20 January 2015.

Marquette National Corporation Increases Quarterly Dividend 50%
PR Newswire - Wed Jan 21, 5:30AM CST
Marquette National Corporation (OTCQX: MNAT) today announced that its Board of Directors declared a cash dividend of $0.375 per share, an increase of 50% from the previous quarter dividend rate. The dividend will be payable on April 1, 2015 to shareholders of record on March 20, 2015. As of January 20, 2015, Marquette had 1,025,109 shares issued and outstanding.

Marquette National redeems all outstanding series A and B preferred stock for USD14.2m
M2 - Wed Dec 31, 8:40AM CST
Marquette National Corporation (OTCQX:MNAT), a diversified bank holding company, has redeemed all 14,189 remaining outstanding shares of its series A and B preferred stock, it disclosed on Tuesday.

Marquette National Corporation Completes the Redemption of Preferred Stock
PR Newswire - Tue Dec 30, 7:30AM CST
Marquette National Corporation (OTCQX: MNAT) today announced that it has redeemed all 14,189 remaining outstanding shares of its Series A and Series B Preferred Stock. The total redemption amount was $14,189,000 plus accrued and unpaid dividends. To fund the redemption, the Company utilized excess capital from its banking subsidiary, Marquette Bank.

Marquette National Corporation to Redeem its Outstanding Preferred Stock
PR Newswire - Fri Nov 28, 11:30AM CST
Marquette National Corporation (OTCQX: MNAT) today announced that it intends to redeem all 14,189 shares of its outstanding Series A and Series B Preferred Stock, each with a liquidation value of $1,000 per share. The total redemption amount will be $14,189,000 plus accrued and unpaid dividends. The redemption is expected to be completed at the end of December 2014.

Marquette National announces dividend of USD0.25 per share
M2 - Thu Oct 23, 6:15AM CDT
The board of directors of Marquette National Corporation (OTCQX:MNAT), a diversified bank holding company, authorised a cash dividend of USD0.25 per share, on the company's 1,025,107 issued and outstanding shares as of 21 October 2014, it announced on Wednesday.

Marquette National Corporation Declares Dividend of $0.25 per Share
PR Newswire - Wed Oct 22, 8:22AM CDT
Marquette National Corporation (OTCQX: MNAT) today announced that its Board of Directors declared a cash dividend of $0.25 per share. The dividend will be payable on January 2, 2015 to shareholders of record on December 19, 2014. As of October 21, 2014, Marquette had 1,025,107 shares issued and outstanding.

Marquette National Corporation Shares Commence Trading on OTCQX Marketplace
PR Newswire - Mon Aug 04, 4:16PM CDT
Marquette National Corporation (OTCQX: MNAT) today announced that its common stock began trading today on the OTCQX marketplace, operated by OTC Markets Group. Prior to this, the Company's shares traded on the OTCQB marketplace. The Company's stock symbol, "MNAT", remains the same.

OTC Markets Group Welcomes Marquette National Corporation to OTCQX®
PR Newswire - Mon Aug 04, 6:00AM CDT
OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that Marquette National Corporation (OTCQX: MNAT), the parent company of Marquette Bank, has qualified to trade on OTCQX®, The Best Marketplace.

Marquette National announces dividend of USD0.25 per share for quarter
M2 - Thu Jul 24, 3:01AM CDT
The board of directors of Marquette National Corporation (OTC:MNAT), a diversified bank holding company, approved a cash dividend of USD0.25 per share on a post-stock-split basis, which equals the pre-stock-split cash dividend of USD1.00 per share released in the prior quarter, the company disclosed on Wednesday.

Marquette National Corporation Announces Four-for-One Stock Split
PR Newswire - Wed Jul 02, 3:23PM CDT
Marquette National Corporation (OTCQB: MNAT) today announced that its Board of Directors declared a four-for-one stock split of its common stock payable in the form of a stock dividend. The four-for-one stock split will be payable on August 1, 2014 to shareholders of record on July 18, 2014. The Company currently has 256,429 shares of common stock issued and outstanding. The last reported sales price for the common stock was $315.00. After the stock split, the current number of shares of common stock outstanding will increase to 1,025,716 shares, and the per share price will be adjusted.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

FuboTV Prepares for Q3 2024 Financial Results Release

Updated Category News Views 101

FuboTV to Reveal Q3 2024 Financial Insights FuboTV Inc. (d/b/a Fubo) (NYSE: FUBO), a prominent player in the sports streaming arena, has announced a significant event on the horizon. They will release their third quarter financial results for 2024 early in the market day, a move that provides a valuable update for investors and followers alike. Details about the Financial...

Continue Reading
Coinbase's Gokul Rajaram's Share Sale Highlights Market Trends

Updated Category News Views 262

Gokul Rajaram of Coinbase Sells Shares Recently, Gokul Rajaram, a director at Coinbase Global, Inc. (NASDAQ:COIN), made headlines by selling shares worth $64,536. This transaction took place in September, when he sold 400 shares at a price of $161.34 each. Such moves often attract a lot of attention from those tracking the cryptocurrency market and its developments...

Continue Reading
Robinhood's New Fund Unlocks Private AI Investments for All

Updated Category News Views 200

Robinhood Ventures' Bold Move Into Private AI Investments Robinhood Markets Inc. (NASDAQ: HOOD) is set to revolutionize the investment landscape by giving retail investors access to private startups focused on artificial intelligence (AI). Despite widespread chatter about a potential bubble in the AI sector, the company is moving forward with this innovative approach....

Continue Reading
IRG, PREP, and DWREP Join Forces for Major Site Redevelopment

Updated Category News Views 184

Investment in Future Growth In an exciting development, Industrial Realty Group, LLC (IRG), along with Provider Real Estate Partners (PREP) and DW Real Estate Partners, LLC (DWREP), have embarked on a significant project to redevelop an industrial property in Ohio. The trio has successfully acquired the Hilliard Commerce Center, a sprawling 177,680 square-foot facility...

Continue Reading
Understanding Publicis Groupe’s Recent Share Trading Activity

Updated Category News Views 149

Overview of Share Trading Activities Publicis Groupe recently engaged in notable share trading activities, reflecting its strategic moves in the market. This trading involves shares acquired as part of a pre-approved program by the company's shareholders, aimed at enhancing its capital management. Transaction Details During the latest trading window, Publicis Groupe...

Continue Reading